jamunjar-logo
whatsapp
cartmembermenu
Search for
"test & packages"
"physiotherapy"
"heart"
"lungs"
"diabetes"
"kidney"
"liver"
"cancer"
"thyroid"
"bones"
"fever"
"vitamin"
"iron"
"HTN"

Mycoplasma Pneumoniae IgM

Lung
image

Report in 168Hrs

image

At Home

nofastingrequire

No Fasting Required

Details

Used for early diagnosis of recent or active Mycoplasma infection

2,5453,215

21% OFF

Mycoplasma Pneumoniae IgM - Comprehensive Medical Test Information Guide

  • Why is it done?
    • Test Purpose: This test detects IgM antibodies against Mycoplasma pneumoniae, a bacterium that causes atypical pneumonia and other respiratory infections. IgM antibodies are produced during the early stages of infection.
    • Primary Indications: Diagnosis of acute Mycoplasma pneumoniae infection; evaluation of atypical pneumonia; suspected walking pneumonia; persistent cough with fever; respiratory symptoms suggestive of M. pneumoniae infection; immunocompromised patients with respiratory symptoms.
    • Typical Timing: Performed during the acute phase of illness (first 1-2 weeks of symptoms); most useful within the first 2-3 weeks of infection when IgM antibodies are at peak levels; repeat testing may be done after 2-4 weeks if initial results are negative but clinical suspicion remains high.
  • Normal Range
    • Reference Values: Negative: <0.9 Index (or <1:16 titer depending on lab methodology); Positive: ≥1.1 Index (or ≥1:32 titer); Borderline/Equivocal: 0.9-1.0 Index (may require repeat testing).
    • Units of Measurement: Index units (or reciprocal titer ratios); commonly expressed as negative/positive or specific antibody levels measured via ELISA, immunofluorescence, or chemiluminescence immunoassay.
    • Interpretation: Negative result indicates no current acute infection; Positive result suggests acute or recent M. pneumoniae infection; Borderline results require clinical correlation and possible repeat testing; results should be interpreted alongside clinical presentation, symptoms duration, and other diagnostic findings.
  • Interpretation
    • Positive IgM Result: Indicates acute M. pneumoniae infection; patient likely in early stages of disease (within 1-4 weeks); consistent with symptomatic respiratory infection; requires clinical confirmation with symptoms such as cough, fever, malaise, and respiratory findings.
    • Negative IgM Result: Suggests absence of acute infection; may indicate very early infection (before antibody formation); or past infection with IgM decline; in early illness (<1 week), negative result does not exclude infection.
    • High Titers: Strong evidence of acute infection; typically occur in second to fourth week of illness; greater likelihood of active M. pneumoniae disease; may correlate with severity of clinical symptoms.
    • Borderline/Equivocal Results: Require repeat testing after 7-10 days; rising titers suggest acute infection; stable or falling titers suggest past infection or false positive; clinical correlation is essential.
    • Factors Affecting Results: Timing of specimen collection relative to symptom onset; individual immune response variation; immunocompromised status; antibiotic therapy (may reduce antibody production if started very early); cross-reactivity with other pathogens; laboratory methodology variations; concomitant infections.
  • Associated Organs
    • Primary Organ System: Respiratory system (lungs, bronchi, trachea, bronchioles); upper and lower respiratory tract involvement; can affect mucosal epithelium and cause inflammation.
    • Commonly Associated Conditions: Atypical pneumonia (walking pneumonia); acute bronchitis; tracheobronchitis; pharyngitis; otitis media; sinusitis; exacerbation of asthma; chronic obstructive pulmonary disease (COPD) exacerbation; bronchiectasis.
    • Extrapulmonary Complications: Myocarditis (heart muscle inflammation); pericarditis (pericardium inflammation); hemolytic anemia; Stevens-Johnson syndrome; erythema multiforme; encephalitis (rare); meningitis (rare); arthralgia and arthritis; vasculitis.
    • Potential Complications: Severe pneumonia requiring hospitalization; respiratory failure in severe cases; immunocompromised patients at higher risk for severe disease; recurrent infections possible; post-infection cough that may persist for weeks; secondary bacterial superinfection.
  • Follow-up Tests
    • Confirmatory Tests: Mycoplasma pneumoniae IgG antibodies (indicates past infection or late acute infection); Mycoplasma pneumoniae PCR (polymerase chain reaction) for direct organism detection; M. pneumoniae culture (gold standard but slow); chest X-ray to assess pneumonia severity.
    • Additional Diagnostic Tests: Cold agglutinin test (complement-fixing antibodies); complete blood count (CBC); liver function tests; respiratory viral panel (to rule out other pathogens); sputum culture and Gram stain; blood cultures if bacteremia suspected.
    • Monitoring Tests: Serial IgM testing (repeat at 7-10 days if initial negative and high clinical suspicion); IgG testing at 2-4 weeks for convalescent phase confirmation; follow-up chest imaging if pneumonia diagnosed; clinical symptom assessment at 2-4 weeks.
    • Specialized Tests: Echocardiogram if myocarditis suspected; cardiac troponin and BNP for cardiac involvement; electrocardiogram (ECG); pulmonary function tests if chronic symptoms; skin biopsy if Stevens-Johnson syndrome suspected.
  • Fasting Required?
    • Fasting Status: NO - Fasting is not required for this test.
    • Patient Preparation: No special dietary restrictions; patient may eat and drink normally before blood draw; maintain regular hydration; arrive with adequate time for specimen collection.
    • Specimen Collection: Serum sample (3-5 mL blood); standard venipuncture with appropriate collection tube; separate serum from blood cells; protect from light when applicable; proper labeling with patient information and time of collection.
    • Medications: No medications need to be withheld before this test; antibiotics (macrolides, tetracyclines, fluoroquinolones) do not interfere with IgM antibody detection; continue all routine medications as directed by physician.
    • Timing Considerations: Specimen should be collected during symptomatic period (ideally within 1-2 weeks of symptom onset); early morning collection preferred but not required; avoid excessive arm movement before venipuncture to prevent hemolysis.

How our test process works!

customers
customers